Dividends Calendar Earnings Calendar
FATE

FATE | Fate Therapeutics Inc

Healthcare sector
Fate Therapeutics Inc
Category: Consumer goods
  • Industry: Biotechnology

Quick infos

  • Headquarters:   La Jolla, California, United States

Trade prices

  • Volume:
  • Market Cap: 2.43B
  • Prev closed:
  • Open: 39.1
  • High: 42.34
  • Low: 39.1
  • 52 week low: 29.4
  • 52 week high: 97.43
  • Dividends:No Dividends

Next ER: February 28, 2023  After Market Closes



Top Stories (FATE)

    Company Profile

    We are a biopharmaceutical company dedicated to the development of programmed cellular immunotherapies. Our pipeline is comprised of cell-based therapies for cancer and immune disorders. Our cellular immunotherapies are based on our novel ex vivo cell programming approach, which we apply to modulate the therapeutic function and direct the fate of hematopoietic cells.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    May 3, 2023
    February 28, 2023-0.58 / -0.8644.34M / 17.88MBeat!
    November 3, 2022-0.86 / -0.8914.98M / 15.63M
    August 3, 2022-0.79 / -0.829118.55M / 12.54MBeat!
    May 4, 2022-0.68 / -0.765118.41M / 9.01MBeat!
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Aug 3, 2022 32.81 31.99
    34.31
    31.70
    		 1.49M 7.12%
    Aug 2, 2022 30.63 30.02
    31.06
    29.51
    		 977.74K 1.96%
    Aug 1, 2022 30.04 30.05
    31.77
    29.83
    		 882.21K -1.6%
    Jul 29, 2022 30.53 31.57
    31.79
    30.37
    		 943.03K -5.04%
    Jul 28, 2022 32.15 33.20
    34.01
    30.57
    		 880.13K -3.08%
    Jul 27, 2022 33.17 31.96
    33.32
    31.16
    		 1.03M 5.70%
    Jul 26, 2022 31.38 30.69
    32.26
    30.21
    		 769.83K 2.08%
    Jul 25, 2022 30.74 31.04
    31.15
    29.73
    		 943.09K -0.97%
    Jul 22, 2022 31.04 33.59
    33.84
    30.98
    		 1.28M -6.9%
    Jul 21, 2022 33.34 32.52
    33.36
    31.82
    		 883.97K 2.14%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2007
    • Employees:356

    News

    News for (FATE)

    This company doesn't provide a dividend.

    Key Persons

    • CEO :  J. Scott Wolchko
    • CFO :  Edward Dulac

    Talk about Fate Therapeutics Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Feb 28, 2023 (Same day)

    hpq a urbn tgt aap dk sjm eog azo rost sre mnst 


    Jump to (Finance sites)

    Google   
             

    Research 


    Investor page

    ir.fatetherapeutics.com

    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 29
    HOLD 62
    SELL 10

    Their Official Profiles 

    TwitterLinkedIn

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    The Internet of Money
    Buy on Amazon

    While many books explain the how of bitcoin, The Internet of Money delves into the why of bitcoin. Acclaimed information-security expert and author of Mastering Bitcoin, Andreas M. Antonopoulos examines and contextualizes the significance of bitcoin through a series of essays spanning the exhilarating maturation of this technology.